Ablynx's Series B Round

Ablynx raised a round of funding on April 01, 2004.

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies to treat a range of serious human diseases. Nanobodies are a novel class of antibody-derived therapeutic pr…

Articles about Ablynx's Series B Round: